19 h. ago CSRC vows deeper reforms to open China’s capital market and boost tech listings

China’s top securities regulator has pledged to widen foreign investors’ access to the mainland’s capital market while further lowering the fundraising threshold for technology firms, after a key indicator slumped nearly 4 per cent from a 10-year high in mid-November. Wu Qing, chairman of the China Securities Regulatory Commission (CSRC), set out guidance for the equity and bond markets in an article published by the Communist Party mouthpiece People’s Daily on Friday, three weeks after he was...

Politics

6 d. ago China sets up new regulatory body to oversee rapid growing commercial space sector

China sets up new regulatory body to oversee rapid growing commercial space sector  Global Times

Politics

7 d. ago DeepSeek, Alibaba researchers endorse China’s AI regulatory framework

Researchers from artificial intelligence start-up DeepSeek and tech giant Alibaba Group Holding have endorsed China’s emerging AI regulatory framework while calling for clearer feedback in a paper published in the US journal Science. The paper, published last month under the title “China’s emerging regulation towards an open future for AI”, said the country had so far facilitated an “innovation- and openness-friendly institutional environment for AI developers” but that it could be further...

Politics

1 week ago China Issues New Regulatory Guidelines to Accelerate Cosmetics Innovation and Market Entry

China Issues New Regulatory Guidelines to Accelerate Cosmetics Innovation and Market Entry  Global Cosmetics News

Economics

2 w. ago Top Democrat demands probe into 4 Chinese firms potentially supplying Nexperia

A senior US Democrat is urging the Commerce Department to investigate four Chinese semiconductor firms potentially tied to Dutch chipmaker Nexperia, warning they could threaten the safety and reliability of components used in cars across the US and its allies. The request marks the latest twist in the turmoil surrounding the Chinese-owned firm, which has become a flashpoint in broader disputes involving China, Europe, and the US, following months of internal conflicts, regulatory intervention...

Politics

2 w. ago Top Democrat demands US probe into Chinese firms potentially supplying Nexperia

A senior US Democrat is urging the Commerce Department to investigate four Chinese semiconductor firms potentially tied to Dutch chipmaker Nexperia, warning they could threaten the safety and reliability of components used in cars across the US and its allies. The request marks the latest twist in the turmoil surrounding the Chinese-owned firm, which has become a flashpoint in broader disputes involving China, Europe, and the US, following months of internal conflicts, regulatory intervention...

Politics

3 w. ago China’s market regulator appears in public after resignation report

China’s top securities watchdog appeared in public just hours after he was reported to have offered his resignation, in what analysts said could be an effort by authorities to prevent market destabilisation. The China Securities Regulatory Commission (CSRC) said in a statement on Thursday that its chairman Wu Qing was travelling to France and Brazil from November 10 to 13. It also displayed photos on its website of Wu taking part in meetings in the two countries. The prompt and rare publicity of...

Politics

3 w. ago Exclusive: China’s securities regulatory chief seeks approval to step down, sources say

Exclusive: China’s securities regulatory chief seeks approval to step down, sources say  Reuters

Politics

3 w. ago China’s securities regulatory chief seeks approval to step down, sources say

China’s securities regulatory chief seeks approval to step down, sources say  TradingView

Politics

4 w. ago Latest Updates to Fertilizer Registration Requirements in China

Latest Updates to Fertilizer Registration Requirements in China - Regulatory News - Agrochemicals  CIRS Group

Politics

4 w. ago Can Illumina’s (ILMN) Clinical Growth Offset Ongoing Regulatory Challenges in China?

Can Illumina’s (ILMN) Clinical Growth Offset Ongoing Regulatory Challenges in China?  Yahoo! Finance UK

Science